929 related articles for article (PubMed ID: 17617403)
1. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
Zaniewska M; McCreary AC; Przegaliński E; Filip M
Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment.
Zaniewska M; McCreary AC; Wydra K; Filip M
Synapse; 2010 Jul; 64(7):511-9. PubMed ID: 20196140
[TBL] [Abstract][Full Text] [Related]
3. Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice.
Fantegrossi WE; Simoneau J; Cohen MS; Zimmerman SM; Henson CM; Rice KC; Woods JH
J Pharmacol Exp Ther; 2010 Dec; 335(3):728-34. PubMed ID: 20858706
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of nicotine's discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A/2C receptor agonists.
Batman AM; Munzar P; Beardsley PM
Psychopharmacology (Berl); 2005 May; 179(2):393-401. PubMed ID: 15565434
[TBL] [Abstract][Full Text] [Related]
5. Interactions of serotonin (5-HT)2 receptor-targeting ligands and nicotine: locomotor activity studies in rats.
Zaniewska M; McCreary AC; Filip M
Synapse; 2009 Aug; 63(8):653-61. PubMed ID: 19347958
[TBL] [Abstract][Full Text] [Related]
6. Effects of 5-HT
Fletcher PJ; Zeeb FD; Browne CJ; Higgins GA; Soko AD
Psychopharmacology (Berl); 2017 Mar; 234(5):889-902. PubMed ID: 28097374
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist.
Damjanoska KJ; Muma NA; Zhang Y; D'Souza DN; Garcia F; Carrasco GA; Kindel GH; Haskins KA; Shankaran M; Petersen BR; Van De Kar LD
J Pharmacol Exp Ther; 2003 Mar; 304(3):1209-16. PubMed ID: 12604698
[TBL] [Abstract][Full Text] [Related]
8. Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis.
Dekeyne A; Girardon S; Millan MJ
Neuropharmacology; 1999 Mar; 38(3):415-23. PubMed ID: 10219979
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
10. Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens.
De Deurwaerdère P; Navailles S; Berg KA; Clarke WP; Spampinato U
J Neurosci; 2004 Mar; 24(13):3235-41. PubMed ID: 15056702
[TBL] [Abstract][Full Text] [Related]
11. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
[TBL] [Abstract][Full Text] [Related]
12. Contribution of serotonin (5-HT) 5-HT2 receptor subtypes to the discriminative stimulus effects of cocaine in rats.
Filip M; Bubar MJ; Cunningham KA
Psychopharmacology (Berl); 2006 Jan; 183(4):482-9. PubMed ID: 16261316
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
Zaniewska M; McCreary AC; Przegaliński E; Filip M
Eur J Pharmacol; 2006 Jul; 540(1-3):96-106. PubMed ID: 16730696
[TBL] [Abstract][Full Text] [Related]
14. WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity.
Marquis KL; Sabb AL; Logue SF; Brennan JA; Piesla MJ; Comery TA; Grauer SM; Ashby CR; Nguyen HQ; Dawson LA; Barrett JE; Stack G; Meltzer HY; Harrison BL; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 2007 Jan; 320(1):486-96. PubMed ID: 17038512
[TBL] [Abstract][Full Text] [Related]
15. Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(+/-)DOI] in C57BL/6J mice.
Smith RL; Barrett RJ; Sanders-Bush E
Psychopharmacology (Berl); 2003 Feb; 166(1):61-8. PubMed ID: 12474110
[TBL] [Abstract][Full Text] [Related]
16. Serotonin1A autoreceptor activation by S 15535 enhances circadian activity rhythms in hamsters: evaluation of potential interactions with serotonin2A and serotonin2C receptors.
Gannon RL; Millan MJ
Neuroscience; 2006; 137(1):287-99. PubMed ID: 16289351
[TBL] [Abstract][Full Text] [Related]
17. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
18. Directly Observable Behavioral Effects of Lorcaserin in Rats.
Serafine KM; Rice KC; France CP
J Pharmacol Exp Ther; 2015 Dec; 355(3):381-5. PubMed ID: 26384326
[TBL] [Abstract][Full Text] [Related]
19. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats.
Li JX; Unzeitig A; Javors MA; Rice KC; Koek W; France CP
J Pharmacol Exp Ther; 2009 Nov; 331(2):671-9. PubMed ID: 19687292
[TBL] [Abstract][Full Text] [Related]
20. Discriminative stimulus properties of (+/-)-fenfluramine: the role of 5-HT2 receptor subtypes.
McCreary AC; Filip M; Cunningham KA
Behav Neurosci; 2003 Apr; 117(2):212-21. PubMed ID: 12708517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]